Invesaro

Stocks Health care ZJYL

NASDAQ · Health care

Jin Medical International Ltd. (ZJYL)

Jin Medical International Ltd. reported revenue of $20.7M in fiscal 2025, down 12.0% from a year earlier. Net income was $1.2M, a net margin of 5.8%. In fiscal 2025 capital spending exceeded operating cash flow by $3.7M. At September 30, 2025 it held $7.5M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on February 10, 2026.

Free, no password. An email when ZJYL files with the SEC.

Price
$4.02
+1.65% on the day · November 10, 2026
52-week range $1.53 to $5.68
Market cap
$314.9M
Revenue (FY2025)
$20.7M
-12.0% year on year
Net margin
5.8%

Key facts about Jin Medical International Ltd.

Net worth
Jin Medical International Ltd. has a market value (market cap) of $314.9M at the latest share price, and shareholders' equity of $29.6M on its balance sheet at September 30, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $20.7M (-12.0% year on year), with net income of $1.2M.
Cash flow
In fiscal 2025 operations brought in $2.9M of cash; after $6.6M of capital spending, free cash flow was -$3.7M.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on February 10, 2026 and covers the period to September 30, 2025. Open on SEC EDGAR

What Jin Medical International Ltd. does

Jin Medical International Ltd. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker ZJYL.

Revenue and profit by year

Revenue
FY21: $20.8M $20.8M FY21FY23: $19.2M $19.2M FY23FY23: $19.8M $19.8M FY23FY24: $23.5M $23.5M FY24FY25: $20.7M $20.7M FY25
Net income
FY21: $2.6M $2.6M FY21FY23: $2.7M $2.7M FY23FY23: $2.9M $2.9M FY23FY24: $3.7M $3.7M FY24FY25: $1.2M $1.2M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$20.7M$608.2K$1.2M$0.01-$3.7M
2024$23.5M$3.6M$3.7M$0.02-$1.4M
2023$19.8M$2.9M$2.9M$0.02$3M
2023$19.2M$2.1M$2.7M$0.02$1.5M
2021$20.8M$2.6M$2.6M$0.02$5.8M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where ZJYL ranks in Health care

Revenue$20.7M
#471 of 751 in Health care · Bottom 37%
Revenue growth-12.0%
#467 of 532 in Health care · Bottom 12%
Net margin5.8%
#158 of 544 in Health care · Top 29%
Free cash flow margin-18.0%
#322 of 490 in Health care · Bottom 34%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Jin Medical International Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 30, 2026
  2. September 25, 2026
  3. September 24, 2026
  4. September 8, 2026
  5. August 21, 2026
  6. August 18, 2026
  7. August 4, 2026
  8. July 20, 2026
  9. July 15, 2026
  10. June 30, 2026

Recent insider filings (Forms 3, 4 and 144): 7, the latest on July 16, 2026. Insider transactions on SEC

Insider trades

What the people running Jin Medical International Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns ZJYL

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Novastralist Horizon Ltd.13G, passive with 1 related filers 10.46% 7,702,376 August 18, 2026

Latest filings below 5%: Erqi Wang 3.35% (September 25, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 4 managers reported a position.

HolderSharesValueChange on quarter
Osaic Holdings, Inc.3,100$5.6K0
UBS Group AG971$1.8K-252
Hrt Financial LP15,662$28new
Caitong International Asset Management Co., Ltd1$2new

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

No insider reported holdings on a Form 4 in the last 12 months.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about ZJYL

What does Jin Medical International Ltd. do?

Jin Medical International Ltd. is a company in the Health care sector, listed on NASDAQ as ZJYL. Its shares trade on NASDAQ under the ticker ZJYL.

What is Jin Medical International Ltd.'s net worth?

Jin Medical International Ltd. has a market value (market cap) of $314.9M at the latest share price, and shareholders' equity of $29.6M on its balance sheet at September 30, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Jin Medical International Ltd. profitable?

Yes. In fiscal 2025 it reported net income of $1.2M on revenue of $20.7M, a net margin of 5.8%.

How much revenue does Jin Medical International Ltd. make?

In fiscal 2025 Jin Medical International Ltd. reported revenue of $20.7M. That is 12.0% less than a year earlier.

When did Jin Medical International Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on February 10, 2026. It covers the period to September 30, 2025. Its newest filing of any kind is the foreign issuer update from October 30, 2026.

Similar companies

Compare ZJYL with

Compare ZJYL with any company

Follow ZJYL

Get an email when Jin Medical International Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when ZJYL files with the SEC.

Where the numbers come from

Financial figures are the values Jin Medical International Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.